Kwaliteitsbeoordelingformulieren voor klinisch onderzoek

De methodologische kwaliteit van elke geïncludeerde studieis geëvalueerd met behulp van NICE-checklists (NICE, 2009). De checklists voor systema­tische reviews en voor RCT's zijn hieronder geproduceerd (voor overige checklists en verdere informatie over het invullen van deze ljisten, zie The guidelines manual [NICE, 2009]). De ingevulde checklists zijn opgenomen in aanverwant 'Klinisch bewijs: ingevulde methodologische checklists'.

 

NICE. (2009). The guidelines manual. London: National Institute for Health and Clinical Excellence.

 

Methodologische checklist: systematic reviews en meta-analyses

Study identification

Include author, title, reference, year of publication

 

Guideline topic: ...

Review question no: ...

Checklist completed by: ...

 

SCREENING QUESTIONS

In a well-conducted, relevant systematic review:

Circle one option for each question

The review addresses an appropriate and clearly focused question that is relevant to the guideline review question

Yes          No           Unclear

The review collects the type of studies you consider relevant to the guideline review question

Yes          No            Unclear

The literature search is sufficiently rigorous to identify all the relevant studies

Yes          No           Unclear

Study quality is assessed and reported

Yes          No           Unclear

An adequate description of the methodology used is included, and the methods used are appropriate to the question

Yes          No           Unclear

 

Methodologische checklist: RCT's

Study identification Include author, title, reference, year of publication

 

Guideline topic:

Review question no:

Checklist completed by:

 

 

Circle one option for each question

A. Selection bias (systematic differences between the comparison groups)

A1

An appropriate method of randomisation was used to allocate participants to treatment groups (which would have balanced any confounding factors equally across groups)

Yes          No           Unclear

N/A

A2

There was adequate concealment of allocation (such that investigators, clinicians and participants cannot influence enrolment or treatment allocation)

Yes          No           Unclear

N/A

A3

The groups were comparable at baseline, including all major confounding and prognostic factors

Yes          No           Unclear

N/A

Based on your answers to the above, in your opinion was selection bias present? If so, what is the likely direction of its effect?

Low risk of bias     Unclear/unknown risk                           High risk of bias

Likely direction of effect:

 

B. Performance bias (systematic differences between groups in the care provided, apart from the intervention under investigation)

B1

The comparison groups received the same care apart from the intervention(s) studied

Yes No Unclear N/A

B2

Participants receiving care were kept 'blind' to treatment allocation

Yes No Unclear N/A

B3

Individuals administering care were kept 'blind' to treatment allocation

Yes No Unclear N/A

Based on your answers to the above, in your opinion was performance bias present? If so, what is the likely direction of its effect?

Low risk of bias              Unclear/unknown risk                              High risk of bias

Likely direction of effect:

 

C. Attrition bias (systematic differences between the comparison groups with respect to loss of participants)

C1

All groups were followed up for an equal length of time (or analysis was adjusted to allow for differences in length of follow-up)

Yes          No Unclear

N/A

C2

  1. How many participants did not complete treatment in each group?

 

b. The groups were comparable for treatment completion (that is, there were no important or systematic differences between groups in terms of those who did not complete treatment)

Yes          No Unclear

N/A

       

C3

a. For how many participants in each group were no outcome data available?

b. The groups were comparable with respect to the availability of outcome data (that is, there were no important or systematic differences between groups in terms of those for whom outcome data were not available).

Yes          No Unclear

N/A

Based on your answers to the above, in your opinion was attrition bias present? If so, what is the likely direction of its effect?

Low risk of bias     Unclear/unknown risk                           High risk of bias

Likely direction of effect:

D. Detection bias (bias in how outcomes are ascertained, diagnosed or verified)

D1

The study had an appropriate length of follow-up

Yes          No Unclear

N/A

D2

The study used a precise definition of outcome

Yes          No Unclear

N/A

D3

A valid and reliable method was used to determine the outcome

Yes          No Unclear

N/A

D4

Investigators were kept 'blind' to participants' exposure to the intervention

Yes          No Unclear

N/A

D5

Investigators were kept 'blind' to other important confounding and prognostic factors

Yes          No Unclear

N/A

Based on your answers to the above, in your opinion was detection bias present? If so, what is the likely direction of its effect?

Low risk of bias     Unclear/unknown risk                           High risk of bias

Likely direction of effect: ...